G. Porebski

In vitro drug causality assessment in Stevens–Johnson syndrome – alternatives for lymphocyte transformation test

W. Pichler, T. Kawabata, G. Porebski, 2013, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Psychometric study of the SF-36v2 in hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE)

W. Aberer, R. A. Campos, H. Farkas, 2021, Orphanet Journal of Rare Diseases.

Secretory leukocyte protease inhibitor regulates nerve reflex‐mediated skin barrier function in psoriasis

J. Cichy, B. Grygier, M. Kwitniewski, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

In vitro diagnosis of T cell‐mediated drug allergy

W. Pichler, G. Porebski, A. Gschwend-Zawodniak, 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

Recombinant human C1‐inhibitor in the treatment of acute angioedema attacks

H. Farkas, M. Soeters, J. Nuijens, 2007, Transfusion.

Recombinant human-C1 inhibitor is effective and safe for repeat hereditary angioedema attacks.

J. Bernstein, M. Riedl, A. Reshef, 2015, The journal of allergy and clinical immunology. In practice.

Sustained Response Following Acute Treatment Of Hereditary Angioedema Attacks With Recombinant Human C1 Esterase Inhibitor

J. Bernstein, W. Lumry, H. Farkas, 2014 .

Deciphering the Genetics of Primary Angioedema with Normal Levels of C1 Inhibitor

H. Farkas, M. Bova, S. D. Del Giacco, 2020, Journal of clinical medicine.

In vitro diagnosis of T cell‐mediated drug allergy

G. Porebski, A. Gschwend-Zawodniak, W. J. Pichler, 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.